Skip to main content

Table 1 The characteristics of patients, surgery, and anesthesia

From: Effects of ramosetron orally disintegrating tablets on the prophylaxis of post-discharge nausea and/or vomiting in female patients undergoing day surgery under general anesthesia: a randomized controlled trial

 

Control (n = 67)

Ramosetron (n = 67)

P

Age (years)

39 (8)

40 (8)

0.344

Weight (kg)

61 (14)

58 (11)

0.257

Height (cm)

160 (5)

160 (5)

0.995

BMI (kg/m2)

23 (5)

22 (4)

0.175

ASA

 

0.136

 1

42 (63%)

50 (75%)

 

 2

25 (37%)

17 (25%)

Anesthesia time (min)

52 (23)

48 (21)

0.219

Surgery time (min)

27(19)

23 (17)

0.198

Previous PONV

1 (1%)

3 (4%)

0.619

Smoking

2 (3%)

4 (6%)

0.680

Types of surgery

 

0.587

 Gynecology

52 (78%)

45 (67%)

 

 ENT

7 (10%)

9 (14%)

 Breast

3 (5%)

5 (7%)

 Orthopedics

2 (3%)

5 (7%)

 Dental

2 (3%)

3 (5%)

 Urology

1 (1%)

0 (0%)

  1. Data are expressed as mean (SD) or number of the patients (proportion)
  2. BMI body mass index, ASA American Society of Anesthesiologists, PONV postoperative nausea and vomiting, ENT ear, nose, and throat